Testing effectiveness (Phase 2)Study completedNCT00940225What this trial is testingStudy of Cabozantinib (XL184) in Adults With Advanced MalignanciesWho this might be right forSolid TumorsCancer Exelixis 730
Testing effectiveness (Phase 2)Looking for participantsNCT06172478What this trial is testingHER3-DXd in Subjects With Locally Advanced or Metastatic Solid TumorsWho this might be right forAdvanced Solid TumorMelanomaHead and Neck Cancer+11 more Daiichi Sankyo 740
Testing effectiveness (Phase 2)UnknownNCT03204019What this trial is testingTegafur Combined With Temozolomide Versus Tegafur Combined With Temozolomide and Thalidomide in Subjects With Advanced Pancreatic Neuroendocrine TumorWho this might be right forPancreatic Neuroendocrine Tumor Chinese Academy of Medical Sciences 60
Not applicableNot Yet RecruitingNCT07014254What this trial is testingTherapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive MalignanciesWho this might be right forPancreatic Ductal Adenocarcinoma (PDAC)Adenocarcinoma of the StomachColorectal Cancer Metastatic+1 more Xijing Hospital 20
Not applicableLooking for participantsNCT06246630What this trial is testingIn Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine TumorWho this might be right forAdvanced Pancreatic Neuroendocrine Tumor Ruijin Hospital 20
Testing effectiveness (Phase 2)Ended earlyNCT03829501What this trial is testingA Phase 1/2, Open-label, Multi-center Study of the Safety and Efficacy of Alomfilimab (KY1044) as Single Agent and in Combination With Anti-PD-L1 (Atezolizumab) in Adult Patients With Selected Advanced MalignanciesWho this might be right forSquamous Cell Carcinoma of Head and NeckNon-small Cell Lung CancerHepatocellular Carcinoma+9 more Kymab Limited 222
Testing effectiveness (Phase 2)Looking for participantsNCT04895709What this trial is testingBMS-986340 as Monotherapy and in Combination With Nivolumab or Docetaxel in Participants With Advanced Solid TumorsWho this might be right forCervical CancerGastric/Gastroesophageal Junction AdenocarcinomaMicrosatellite Stable Colorectal Cancer+8 more Bristol-Myers Squibb 949
Testing effectiveness (Phase 2)Ended earlyNCT02605083What this trial is testingA Dose Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Advanced Solid TumorsWho this might be right forCancer Effector Therapeutics 66
Testing effectiveness (Phase 2)Active Not RecruitingNCT04140526What this trial is testingSafety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorMetastatic Melanoma+16 more OncoC4, Inc. 733
Testing effectiveness (Phase 2)UnknownNCT05199584What this trial is testingA Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function MutationsWho this might be right forSolid Tumors With PTCH1 Loss-of-function Mutations Endeavor Biomedicines, Inc. 44
Early research (Phase 1)Looking for participantsNCT06910657What this trial is testingIDOV-Immune for Advanced Solid TumorsWho this might be right forColorectal CancerPancreatic CancerMelanoma+13 more ViroMissile, Inc. 78
Testing effectiveness (Phase 2)UnknownNCT03963193What this trial is testingEtoposide/Cisplatin Compared With Irinotecan/Cisplatin for Advanced Gastrointestinal Neuroendocrine Tumor G3 TypeWho this might be right forGastrointestinal Neuroendocrine Tumor Henan Cancer Hospital 112
Testing effectiveness (Phase 2)Ended earlyNCT01562899What this trial is testingMEK162 and AMG 479 in Patients With Selected Solid TumorsWho this might be right forMetastatic Pancreatic AdenocarcinomaBRAF Mutated Melanoma Pfizer 77
Testing effectiveness (Phase 2)Ended earlyNCT03736720What this trial is testingLiposomal Irinotecan, Fluorouracil and Leucovorin in Treating Patients With Refractory Advanced High Grade Neuroendocrine Cancer of Gastrointestinal, Unknown, or Pancreatic OriginWho this might be right forLocally Advanced Digestive System Neuroendocrine CarcinomaLocally Advanced Pancreatic Neuroendocrine CarcinomaMetastatic Digestive System Neuroendocrine Carcinoma+5 more Roswell Park Cancer Institute 11
Testing effectiveness (Phase 2)Study completedNCT02259725What this trial is testingRegorafenib in Treating Patients With Advanced or Metastatic Neuroendocrine TumorsWho this might be right forGastrinomaGlucagonomaInsulinoma+6 more University of Southern California 3
Early research (Phase 1)Study completedNCT00005842What this trial is testingTrastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic CancerWho this might be right forCancer National Cancer Institute (NCI) 24
Early research (Phase 1)Active Not RecruitingNCT03983954What this trial is testingNaptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.Who this might be right forER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more NeoTX Therapeutics Ltd. 120
Early research (Phase 1)UnknownNCT03098160What this trial is testingImmunotherapy Study of Evofosfamide in Combination With IpilimumabWho this might be right forPancreatic CancerMelanomaSquamous Cell Carcinoma of the Head and Neck+1 more Threshold Pharmaceuticals 69
Not applicableLooking for participantsNCT06028724What this trial is testingA Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)Who this might be right forSolid TumorAdvanced Solid TumorLocally Advanced Solid Tumor+11 more Centro di Riferimento Oncologico - Aviano 782
Not applicableEnded earlyNCT03073473What this trial is testingEvaluation of the NantHealth GPS Cancer Test in Patients With Advanced CancersWho this might be right forPancreatic CancerMetastatic Breast CancerMetastatic Lung Cancer+3 more Cota Inc. 40